Early human trial of COVID-19 vaccine shows it’s effective: China’s CNBG
China National Biotec Group (CNBG) on Sunday said early human test results for its coronavirus vaccine candidate suggested it could be safe and effective. The experimental shot induced high-level antibodies in all inoculated participants in
China National Biotec Group (CNBG) on Sunday said early human test results for its coronavirus vaccine candidate suggested it could be safe and effective. The experimental shot induced high-level antibodies in all inoculated participants in a Phase 1/2 clinical trial involving 1,120 healthy people. It’s the second vaccine candidate from the firm to show positive results in a clinical trial.
